407 related articles for article (PubMed ID: 18097475)
41. Altered gene expression of adrenomedullin and its receptor system and molecular forms of tissue adrenomedullin in left ventricular hypertrophy induced by malignant hypertension.
Tadokoro K; Nishikimi T; Mori Y; Wang X; Akimoto K; Matsuoka H
Regul Pept; 2003 Apr; 112(1-3):71-8. PubMed ID: 12667627
[TBL] [Abstract][Full Text] [Related]
42. Loss of receptor activity-modifying protein 2 in mice causes placental dysfunction and alters PTH1R regulation.
Kadmiel M; Matson BC; Espenschied ST; Lenhart PM; Caron KM
PLoS One; 2017; 12(7):e0181597. PubMed ID: 28727763
[TBL] [Abstract][Full Text] [Related]
43. Adrenomedullin-RAMP2 system suppresses ER stress-induced tubule cell death and is involved in kidney protection.
Uetake R; Sakurai T; Kamiyoshi A; Ichikawa-Shindo Y; Kawate H; Iesato Y; Yoshizawa T; Koyama T; Yang L; Toriyama Y; Yamauchi A; Igarashi K; Tanaka M; Kuwabara T; Mori K; Yanagita M; Mukoyama M; Shindo T
PLoS One; 2014; 9(2):e87667. PubMed ID: 24505304
[TBL] [Abstract][Full Text] [Related]
44. Adrenomedullin and CGRP interact with endogenous calcitonin-receptor-like receptor in endothelial cells and induce its desensitisation by different mechanisms.
Nikitenko LL; Blucher N; Fox SB; Bicknell R; Smith DM; Rees MC
J Cell Sci; 2006 Mar; 119(Pt 5):910-22. PubMed ID: 16495482
[TBL] [Abstract][Full Text] [Related]
45. Vascular endothelial adrenomedullin-RAMP2 system is essential for vascular integrity and organ homeostasis.
Koyama T; Ochoa-Callejero L; Sakurai T; Kamiyoshi A; Ichikawa-Shindo Y; Iinuma N; Arai T; Yoshizawa T; Iesato Y; Lei Y; Uetake R; Okimura A; Yamauchi A; Tanaka M; Igarashi K; Toriyama Y; Kawate H; Adams RH; Kawakami H; Mochizuki N; Martínez A; Shindo T
Circulation; 2013 Feb; 127(7):842-53. PubMed ID: 23355623
[TBL] [Abstract][Full Text] [Related]
46. Adrenomedullin haploinsufficiency predisposes to secondary lymphedema.
Nikitenko LL; Shimosawa T; Henderson S; Mäkinen T; Shimosawa H; Qureshi U; Pedley RB; Rees MC; Fujita T; Boshoff C
J Invest Dermatol; 2013 Jul; 133(7):1768-76. PubMed ID: 23364478
[TBL] [Abstract][Full Text] [Related]
47. Calcitonin gene-related peptide-evoked sustained tachycardia in calcitonin receptor-like receptor transgenic mice is mediated by sympathetic activity.
Kunz TH; Scott M; Ittner LM; Fischer JA; Born W; Vogel J
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2155-60. PubMed ID: 17660394
[TBL] [Abstract][Full Text] [Related]
48. Phenotypic changes of adrenomedullin receptor components, RAMP2, and CRLR mRNA expression in cultured rat vascular smooth muscle cells.
Makino I; Honda K; Makino Y; Okano I; Kangawa K; Kamiya H; Shibata K; Kawarabayashi T
Biochem Biophys Res Commun; 2001 Nov; 288(3):515-20. PubMed ID: 11676473
[TBL] [Abstract][Full Text] [Related]
49. Adrenomedullin is an autocrine/paracrine growth factor for rat vascular smooth muscle cells.
Shichiri M; Fukai N; Ozawa N; Iwasaki H; Hirata Y
Regul Pept; 2003 Apr; 112(1-3):167-73. PubMed ID: 12667639
[TBL] [Abstract][Full Text] [Related]
50. The calcitonin receptor-like receptor/receptor activity-modifying protein 1 heterodimer can function as a calcitonin gene-related peptide-(8-37)-sensitive adrenomedullin receptor.
Nagoshi Y; Kuwasako K; Ito K; Uemura T; Kato J; Kitamura K; Eto T
Eur J Pharmacol; 2002 Aug; 450(3):237-43. PubMed ID: 12208315
[TBL] [Abstract][Full Text] [Related]
51. Hypoxic induction of receptor activity-modifying protein 2 alters regulation of pulmonary endothelin-1 by adrenomedullin: induction under normoxia versus inhibition under hypoxia.
Dschietzig T; Richter C; Asswad L; Baumann G; Stangl K
J Pharmacol Exp Ther; 2007 Apr; 321(1):409-19. PubMed ID: 17251392
[TBL] [Abstract][Full Text] [Related]
52. Specificity of porcine calcitonin receptor and calcitonin receptor-like receptor in the presence of receptor-activity-modifying proteins.
Kikumoto K; Katafuchi T; Minamino N
Hypertens Res; 2003 Feb; 26 Suppl():S15-23. PubMed ID: 12630807
[TBL] [Abstract][Full Text] [Related]
53. Induction of LYVE-1/stabilin-2-positive liver sinusoidal endothelial-like cells from embryoid bodies by modulation of adrenomedullin-RAMP2 signaling.
Arai T; Sakurai T; Kamiyoshi A; Ichikawa-Shindo Y; Iinuma N; Iesato Y; Koyama T; Yoshizawa T; Uetake R; Yamauchi A; Yang L; Kawate H; Ogawa S; Kobayashi A; Miyagawa S; Shindo T
Peptides; 2011 Sep; 32(9):1855-65. PubMed ID: 21782867
[TBL] [Abstract][Full Text] [Related]
54. Adrenomedullin receptors: molecular identity and function.
Hay DL; Smith DM
Peptides; 2001 Nov; 22(11):1753-63. PubMed ID: 11754961
[TBL] [Abstract][Full Text] [Related]
55. Adrenomedullin stimulates proliferation and inhibits apoptosis of immature rat thymocytes cultured in vitro.
Belloni AS; Trejter M; Malendowicz LK; Nussdorfer GG
Peptides; 2003 Feb; 24(2):295-300. PubMed ID: 12668215
[TBL] [Abstract][Full Text] [Related]
56. Hyperoxia exposure disrupts adrenomedullin signaling in newborn mice: Implications for lung development in premature infants.
Menon RT; Shrestha AK; Shivanna B
Biochem Biophys Res Commun; 2017 Jun; 487(3):666-671. PubMed ID: 28438602
[TBL] [Abstract][Full Text] [Related]
57. Changes in the expression of calcitonin receptor-like receptor, receptor activity-modifying protein (RAMP) 1, RAMP2, and RAMP3 in rat uterus during pregnancy, labor, and by steroid hormone treatments.
Thota C; Gangula PR; Dong YL; Yallampalli C
Biol Reprod; 2003 Oct; 69(4):1432-7. PubMed ID: 12801991
[TBL] [Abstract][Full Text] [Related]
58. Adrenomedullin in the rat testis. I: Its production, actions on testosterone secretion, regulation by human chorionic gonadotropin, and its interaction with endothelin 1 in the leydig cell.
Chan YF; O WS; Tang F
Biol Reprod; 2008 Apr; 78(4):773-9. PubMed ID: 18094363
[TBL] [Abstract][Full Text] [Related]
59. The myocardial response to adrenomedullin involves increased cAMP generation as well as augmented Akt phosphorylation.
Pan CS; Jin SJ; Cao CQ; Zhao J; Zhang J; Wang X; Tang CS; Qi YF
Peptides; 2007 Apr; 28(4):900-9. PubMed ID: 17306419
[TBL] [Abstract][Full Text] [Related]
60. Differential expression of components of the cardiomyocyte adrenomedullin/intermedin receptor system following blood pressure reduction in nitric oxide-deficient hypertension.
Zhao Y; Bell D; Smith LR; Zhao L; Devine AB; McHenry EM; Nicholls DP; McDermott BJ
J Pharmacol Exp Ther; 2006 Mar; 316(3):1269-81. PubMed ID: 16326922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
